Diminished wave reflection in the aorta: A novel physiological action of insulin on large blood vessels

Hypertension

Volumn 33, Issue 5, 1999, Pages 1118-1122

  Westerbacka, Jukka ^c   Wilkinson, Ian ^a   Cockcroft, John ^b   Utriainen, Tapio ^c   Vehkavaara, Satu ^c   Yki Järvinen, Hannele ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Blood pressure; Circulation; Insulin; Pulse wave analysis; Vascular resistance

Indexed keywords

INSULIN;

ADULT; AORTA PRESSURE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HORMONE ACTION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MALE; NORMAL HUMAN; PERIPHERAL CIRCULATION; PRESSURE GRADIENT; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; VASCULAR RESISTANCE;

EID: 0032895748     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.5.1118     Document Type: Article

References (31)

1. Steinberg HO, Brechtel G, Johnson A, Fireberg N, Baron AD. Insulin-mediated skeletal muscle vasodilatation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94: 1172-1179.
2. Yki-Järvinen H, Utriainen T. Insulin-induced vasodilatation: physiology or pharmacology? Diabetologia. 1998;41:369-379.
3. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J Clin Invest. 1990;85:1844-1882.
4. Utriainen T, Malmström R, Mäkimattila S, Yki-Järvinen H. Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia. 1995;38:555-564.
5. Urakami-Harasawa L, Shimokawa H, Nakashima M, Egashira K, Takashita A. Importance of endothelium-derived hyperpolarizing factor in human arteries. J Clin Invest. 1997;100:2793-2799.
6. Kelly RP, Gibbs HH, O'Rourke MF, Daley JE, Mang K, Morgan JJ, Avolio AP. Nitroglycerine has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J. 1990;11:138-144.
7. Safar ME, Bouthier JA, Levenson JA, Simon AC. Peripheral large arteries and the response to antihypertensive treatment. Hypertension. 1983;5(suppl III):63-68.
8. London GM, Pannier B, Vicaut E, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition. J Hypertens. 1996;14: 1139-1146.
9. O'Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertens. 1996; 14:S147-S157.
10. Kelly R, Hayward C, Avolio A, O'Rourke M. Noninvasive determination of age-related changes in the human arterial pulse. Circulation. 1989;80: 1652-1659.
11. O'Rourke MF, Kelly RP. Wave reflection in the systemic circulation and its implications in ventricular function. J Hypertens. 1993;11:327-337.
12. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;231: E214-E223.
13. Kadish AH, Little RL, Sternberg JC. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem. 1968;14:116-131.
14. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J. 1993;14:160-167.
15. Chen C-H, Nevo E, Fetics B, Pak PH, Yin FCP, Maughan L, Kass DA. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Circulation. 1997;95:1827-1836.
16. Hayward CS, Knight DC, Wren BG, Kelly RP. Effects of hormone replacement therapy on non-invasive cardiovascular haemodynamics. J Hypertens. 1997;15:987-993.
17. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
18. Yaginuma T, Avoio A, O'Rourke M, Nichols W, Morgan JJ, Roy P, Baron D, Branson J, Feneley M. Effect of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man. Cardiovasc Res. 1986;20:153-160.
19. Simon AC, Safar ME, Levenson JA, Bouthier JE, Benetos A. Action of vasodilating drugs on small and large arteries of hypertensive patients. J Cardiovasc Pharmacol. 1983;5:626-631.
20. Lambert J, Smulders RA, Aarsen M, Gallay FP, Stehouwer CDA. The acute effect of hyperglycemia on vessel wall properties. Scand J Clin Invest. 1997;57:409-414.
21. Demolis PD, Asmar RG, Levy BI, Safar ME. Non-invasive evaluation of the conduit function and the buffering function of large arteries in man. Clin Physiol. 1991;11:553-564.
22. Cockcroft JR, Wilkinson IB. Commentary: vessel wall properties and cardiovascular risk. J Hum Hypertens. 1998;12:343-344.
23. Wilkinson IB, Fuchs S, Jansen I, Spratt J, Murray GD, Cockcroft JR, Webb DJ. The reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens. 1998;16: 2079-2084.
24. Vollenweider P, Tappy L, Randin D, Schneiter P, Jequier E, Nicod P, Scherrer U. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest. 1993;92:147-154.
25. Vollenweider L, Tappy L, Owlya R, Jequier E, Nicod P, Scherrer U. Insulin-induced sympathetic activation and vasodilatation in skeletal muscle: effects of insulin resistance in lean subjects. Diabetes. 1995;44:641-645.
26. Berne C, Fagius J, Pollare T, Hjemdahl P. The sympathetic response to euglycemic hyperinsulinaemia. Diabetologia. 1992;35:873-879.
27. Safar ME, London GM, Asmar R, Frohlich ED. Recent advances on large arteries in hypertension. Hypertension. 1998;32:156-161.
28. Malmström R, Packard CJ, Watson TDG, Rannikko S, Caslake M, Bedford D, Stewart P, Yki-Järvinen H, Shepherd J, Taskinen M-R. Metabolic basis of hypotrigiyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol. 1997;17:1454-1464.
29. Trovati M, Anfossi G, Cavalot F, Massucco P, Mularoni E, Emanuelli G. Insulin directly reduces platelet sensitivity to aggregating agents: studies in vitro and in vivo. Diabetes. 1988;37:780-786.
30. Trovati M, Mularoni E, Burzacca S, Ponziani MC, Massucco P, Mattiello L, Piretto V, Cavalot F, Anfossi G. Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients. Diabetes. 1995;44:1318-1322.
31. Malmström R, Packard CJ, Caslake M, Bedford D, Steward P, Yki-Järvinen H, Shepherd J, Taskinen M-R. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia. 1997; 40:454-462.